June 13, 2018 / 4:01 PM / in 6 months

BRIEF-Genentech says FDA Approved Avastin Plus Chemotherapy As Treatment For Advanced Ovarian Cancer After Surgery

June 13 (Reuters) - Genentech :

* FDA APPROVES GENENTECH’S AVASTIN (BEVACIZUMAB) PLUS CHEMOTHERAPY AS A TREATMENT FOR WOMEN WITH ADVANCED OVARIAN CANCER FOLLOWING INITIAL SURGERY

* GENENTECH SAYS AVASTIN IS NOW APPROVED FOR TEN DISTINCT USES ACROSS SIX DIFFERENT TYPES OF CANCER IN UNITED STATES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below